| Name | Hanger Clinic |
|---|---|
| Organization Name | Hanger Prosthetics & Orthotics East Inc |
| Location | 2815 West Walnut St, Ste A, Rogers, Arkansas 72756 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (479) 631-9100 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In much the same way that glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University and collaborators have identified a new biosensing platform that could be used to remotely detect and determine treatment options for HIV, E-coli, Staphylococcus aureas and other bacteria.
Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, announced today that it has signed an agreement to serve as exclusive publisher of Pathology effective January 1, 2011. The Royal College of Pathologists of Australasia (RCPA), which produces Pathology, is responsible for the training and professional development of pathologists and for the promotion of the science and practice of pathology.
ACTIVATE, the innovative, enhanced vitamin beverage ideal for people with active lifestyles, today announced it will extend its sustainability efforts and partner with American Forests to celebrate Earth Month through a unique "Plant a Tree" in-store initiative.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
› Verified 1 days ago
| NPI Number | 1275607137 |
| Organization Name | HANGER PROSTHETICS & ORTHOTICS EAST INC |
| Doing Business As | HANGER CLINIC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2815 W Walnut St Ste A, Rogers, AR 72756 |
| Phone Number | 479-631-9100 |
News Archive
In much the same way that glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University and collaborators have identified a new biosensing platform that could be used to remotely detect and determine treatment options for HIV, E-coli, Staphylococcus aureas and other bacteria.
Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, announced today that it has signed an agreement to serve as exclusive publisher of Pathology effective January 1, 2011. The Royal College of Pathologists of Australasia (RCPA), which produces Pathology, is responsible for the training and professional development of pathologists and for the promotion of the science and practice of pathology.
ACTIVATE, the innovative, enhanced vitamin beverage ideal for people with active lifestyles, today announced it will extend its sustainability efforts and partner with American Forests to celebrate Earth Month through a unique "Plant a Tree" in-store initiative.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
› Verified 1 days ago
News Archive
In much the same way that glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University and collaborators have identified a new biosensing platform that could be used to remotely detect and determine treatment options for HIV, E-coli, Staphylococcus aureas and other bacteria.
Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, announced today that it has signed an agreement to serve as exclusive publisher of Pathology effective January 1, 2011. The Royal College of Pathologists of Australasia (RCPA), which produces Pathology, is responsible for the training and professional development of pathologists and for the promotion of the science and practice of pathology.
ACTIVATE, the innovative, enhanced vitamin beverage ideal for people with active lifestyles, today announced it will extend its sustainability efforts and partner with American Forests to celebrate Earth Month through a unique "Plant a Tree" in-store initiative.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
› Verified 1 days ago
Cvs Pharmacy #10816 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1749 W Walnut St, Rogers, Arkansas 72756 Phone: (479) 246-0871 | |
Cvs Pharmacy #17544 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2404 Promenade Blvd, Rogers, Arkansas 72758 Phone: (479) 986-1101 | |
Jp&o Prosthetic & Orthotic Lab Type: Prosthetic/Orthotic Supplier Location: 2103 S 54th St, Rogers, Arkansas 72758 Phone: (479) 319-4543 | |
Womens Pavilion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 122 S 1st St, Rogers, Arkansas 72756 Phone: (479) 936-7050 | |
Boozman Hof Optical Type: Eyewear Supplier (Equipment, not the service) Location: 3737 W Walnut St, Rogers, Arkansas 72756 Phone: (479) 246-1730 |